Wedbush Keeps Their Buy Rating on Neurocrine (NBIX)
In a report released today, Laura Chico from Wedbush maintained a Buy rating on Neurocrine (NBIX – Research Report), with a price target of ...
Wedbush Keeps Their Buy Rating on Oric Pharmaceuticals (ORIC)
Wedbush analyst David Nierengarten maintained a Buy rating on Oric Pharmaceuticals (ORIC – Research Report) today and set a price target of ...